SEC Form 4 · accession 0001209191-16-102142
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pat Cotroneo
Officer — VP, Finance and CFO
Period of report
Feb 22, 2016
Accepted (ET)
Feb 24, 2016 · 9:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 22, 2016 | A | 35,294 | $0.00 | A | 150,246 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $19.39 | Feb 22, 2016 | A | 60,000 | A | — | Feb 22, 2026 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1Represents the grant of restricted stock units that vest over time.
- F2Twenty-five percent of the shares subject to the option vest on March 1, 2017, and the remainder vests in equal amounts quarterly thereafter for the following three years.